NFKB1 and breast carcinoma: These findings may be clinically relevant, since s100A8/A9 levels have been shown to predict breast cancer metastasis (Kwak et al. 2017), and greater NFκB nuclear binding may enhance inflammatory gene expression underlying the CTRA pattern, which was shown to predict disease-free survival in breast cancer patients (Antoni et al. 2016).